Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 76

    1.

    Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases.

    Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM.

    JAMA. 2006 Mar 8;295(10):1127-34.PMID: 16522832 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice.

    Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H.

    Environ Health Perspect. 2006 Mar;114(3):328-33.PMID: 16507453 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Toxic potential of materials at the nanolevel.

    Nel A, Xia T, Mädler L, Li N.

    Science. 2006 Feb 3;311(5761):622-7. Review.PMID: 16456071 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model.

    Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, Aguinaldo JG, Fayad ZA, Fuster V, Lippmann M, Chen LC, Rajagopalan S.

    JAMA. 2005 Dec 21;294(23):3003-10.PMID: 16414948 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Do inhaled carbon nanoparticles translocate directly into the circulation in humans?

    Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee FR, Boon NA, Macnee W, Millar AM, Donaldson K, Newby DE.

    Am J Respir Crit Care Med. 2006 Feb 15;173(4):426-31. Epub 2005 Dec 9.PMID: 16339922 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells.

    Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P.

    Environ Health Perspect. 2005 Nov;113(11):1555-60.PMID: 16263511 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.

    DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R.

    Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7087s-7092s.PMID: 16203807 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Characterization of folate-chitosan-DNA nanoparticles for gene therapy.

    Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, Beaumont E, Fernandes JC.

    Biomaterials. 2006 Mar;27(9):2060-5. Epub 2005 Oct 3.PMID: 16202449 [PubMed - indexed for MEDLINE]Related articles

    9.

    Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.

    El-Sayed IH, Huang X, El-Sayed MA.

    Cancer Lett. 2006 Jul 28;239(1):129-35. Epub 2005 Sep 28.PMID: 16198049 [PubMed - indexed for MEDLINE]Related articles

    10.

    Poly-L-lysine-modified silica nanoparticles: a potential oral gene delivery system.

    Li Z, Zhu S, Gan K, Zhang Q, Zeng Z, Zhou Y, Liu H, Xiong W, Li X, Li G.

    J Nanosci Nanotechnol. 2005 Aug;5(8):1199-203.PMID: 16193977 [PubMed - indexed for MEDLINE]Related articles

    11.

    Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.

    Dufès C, Keith WN, Bilsland A, Proutski I, Uchegbu IF, Schätzlein AG.

    Cancer Res. 2005 Sep 15;65(18):8079-84.PMID: 16166279 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

    Gelperina S, Kisich K, Iseman MD, Heifets L.

    Am J Respir Crit Care Med. 2005 Dec 15;172(12):1487-90. Epub 2005 Sep 8. Review.PMID: 16151040 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor.

    Li Z, Carter JD, Dailey LA, Huang YC.

    Environ Health Perspect. 2005 Aug;113(8):1009-14.PMID: 16079071 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health.

    Delfino RJ, Sioutas C, Malik S.

    Environ Health Perspect. 2005 Aug;113(8):934-46. Review.PMID: 16079061 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain.

    Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N, Bergey EJ, Prasad PN, Stachowiak MK.

    Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11539-44. Epub 2005 Jul 28.PMID: 16051701 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells.

    Prabha S, Labhasetwar V.

    Mol Pharm. 2004 May-Jun;1(3):211-9.PMID: 15981924 [PubMed - indexed for MEDLINE]Related articles

    17.

    Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice.

    Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P.

    Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L698-708. Epub 2005 Jun 10.PMID: 15951334 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.

    Kaul G, Amiji M.

    Pharm Res. 2005 Jun;22(6):951-61. Epub 2005 Jun 8.PMID: 15948039 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators.

    Dockery DW, Luttmann-Gibson H, Rich DQ, Link MS, Mittleman MA, Gold DR, Koutrakis P, Schwartz JD, Verrier RL.

    Environ Health Perspect. 2005 Jun;113(6):670-4.PMID: 15929887 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Atmosphere. Air pollution-related illness: effects of particles.

    Nel A.

    Science. 2005 May 6;308(5723):804-6. No abstract available. Erratum in: Science. 2005 Aug 26;309(5739):1326. PMID: 15879201 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data